Carbapenem-Resistant : Diversity, Virulence, and Antimicrobial Resistance.

Background: () is one of the most important pathogens in nosocomial infections. It has resistance to most antibiotics, even carbapenem, resulting in restricted therapeutic options.

Purpose: We tried to assess the antimicrobial resistance and virulence fitness of carbapenem-resistant (CRKP) in addition to their phenotypic and genotypic diversity.

The First Saudi Study Investigating the Plasmid-borne Aminoglycoside and Sulfonamide Resistance among Clinical Isolates Genotyped by RAPD-PCR: the Declaration of a Novel Allelic Variant Called and Three Novel Mutations in the Gene in the Plasmid (s).

Background: () is one of the most important nosocomial pathogens responsible for a wide range of infections.

Aim: This study aimed to investigate the existence of the plasmidic genes encoding for aminoglycoside modifying enzymes (AMEs), 16S rRNA methyltransferases (RMT), and the altered dihydropetroate synthase (DHPS) encoded by the gene among clinical isolates collected from Taif, Kingdom of Saudi Arabia (KSA). The mutations in  and genes were also investigated.

The First Egyptian Report Showing the Co-Existence of , , , and Among Carbapenem-Resistant Clinical Isolates Genotyped by BOX-PCR.

Background And Objective: The emergence of carbapenem-resistant (CRKP) continues to escalate and is alarming because of the emergence of pan drug-resistant strains. The objective of this study was to investigate the existence of 12 carbapenemase genes among CRKP clinical isolates.

Methods: Ninety-six spp.